Patents by Inventor Priscilla BRIQUEZ

Priscilla BRIQUEZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240092867
    Abstract: The methods and compositions described herein address the need in the art by providing peptides and polypeptides comprising a growth factor binding domain. In some embodiments, the peptides have an amino acid sequence that is at least 80% identical to one of SEQ ID NOS:1-7, 13-15, 49-50, or 66-70, or a fragment thereof; wherein the peptide is less than 300 amino acids in length.
    Type: Application
    Filed: July 13, 2023
    Publication date: March 21, 2024
    Applicants: The University of Chicago, Imperial College Innovations Limited
    Inventors: Jeffrey A. HUBBELL, Anna M. RANDI, Jun ISHIHARA, Ako ISHIHARA, Priscilla BRIQUEZ, Richard STARKE
  • Publication number: 20240044896
    Abstract: Aspects of the disclosure are directed to methods, systems, and compositions for detecting antibodies capable of binding to angiotensin II. Certain aspects comprise detection of antibodies capable of binding to angiotensin II in a sample from a subject, where the subject has or has had a coronavirus infection, such as a SARS-CoV-2 infection. Also disclosed are vaccine compositions comprising a portion of SARS-CoV-2 Spike protein, where such compositions do not induce generation of angiotensin II-binding antibodies.
    Type: Application
    Filed: December 9, 2021
    Publication date: February 8, 2024
    Applicant: The University of Chicago
    Inventors: Melody SWARTZ, Priscilla BRIQUEZ, Jeffrey HUBBELL
  • Patent number: 11732029
    Abstract: The methods and compositions described herein address the need in the art by providing peptides and polypeptides comprising a growth factor binding domain. In some embodiments, the peptides have an amino acid sequence that is at least 80% identical to one of SEQ ID NOS:1-7, 13-15, 49-50, or 66-70, or a fragment thereof; wherein the peptide is less than 300 amino acids in length.
    Type: Grant
    Filed: November 13, 2018
    Date of Patent: August 22, 2023
    Assignees: The University Chicago, Imperial College Innovations Limited
    Inventors: Jeffrey A. Hubbell, Anna M. Randi, Jun Ishihara, Ako Ishihara, Priscilla Briquez, Richard Starke
  • Publication number: 20210040179
    Abstract: The methods and compositions described herein address the need in the art by providing peptides and polypeptides comprising a growth factor binding domain. In some embodiments, the peptides have an amino acid sequence that is at least 80% identical to one of SEQ ID NOS:1-7, 13-15, 49-50, or 66-70, or a fragment thereof; wherein the peptide is less than 300 amino acids in length.
    Type: Application
    Filed: November 13, 2018
    Publication date: February 11, 2021
    Inventors: Jeffrey A. HUBBELL, Anna M. RANDI, Jun ISHIHARA, Ako ISHIHARA, Priscilla BRIQUEZ, Richard STARKE